Genetic Testing for Parkinson's Disease and Movement Disorders in Less Privileged Areas: Barriers and Opportunities.
作者信息
Tan Ai Huey, Cornejo-Olivas Mario, Okubadejo Njideka, Pal Pramod Kumar, Saranza Gerard, Saffie-Awad Paula, Ahmad-Annuar Azlina, Schumacher-Schuh Artur F, Okeng'o Kigocha, Mata Ignacio F, Gatto Emilia M, Lim Shen-Yang
机构信息
Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Neurogenetics Working Group, Universidad Científica del Sur, Lima, Peru.
出版信息
Mov Disord Clin Pract. 2024 Jan;11(1):14-20. doi: 10.1002/mdc3.13903. Epub 2023 Nov 29.
Abstract
摘要
相似文献
1
Genetic Testing for Parkinson's Disease and Movement Disorders in Less Privileged Areas: Barriers and Opportunities.
Mov Disord Clin Pract. 2024 Jan;11(1):14-20. doi: 10.1002/mdc3.13903. Epub 2023 Nov 29.
2
International Genetic Testing and Counseling Practices for Parkinson's Disease.
Mov Disord. 2023 Aug;38(8):1527-1535. doi: 10.1002/mds.29442. Epub 2023 Jun 13.
3
Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.
Brain. 2024 Aug 1;147(8):2668-2679. doi: 10.1093/brain/awae142.
4
[Genetic testing for Parkinson's disease: indication and practical implementation].
Fortschr Neurol Psychiatr. 2020 Sep;88(9):601-608. doi: 10.1055/a-1155-6389. Epub 2020 Jun 28.
5
Genetic analysis of Mendelian mutations in a large UK population-based Parkinson's disease study.
Brain. 2019 Sep 1;142(9):2828-2844. doi: 10.1093/brain/awz191.
6
Test for LRRK2 mutations in patients with Parkinson's disease.
Pract Neurol. 2008 Dec;8(6):381-5. doi: 10.1136/jnnp.2008.162420.
7
Harmonizing Genetic Testing for Parkinson's Disease: Results of the PARKNET Multicentric Study.
Mov Disord. 2023 Dec;38(12):2241-2248. doi: 10.1002/mds.29617. Epub 2023 Sep 26.
8
Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease.
Brain. 2009 Dec;132(Pt 12):3298-307. doi: 10.1093/brain/awp244.
9
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities.
Lancet Neurol. 2013 May;12(5):514-24. doi: 10.1016/S1474-4422(13)70047-4. Epub 2013 Apr 11.
10
A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.
J Parkinsons Dis. 2020;10(3):1195-1207. doi: 10.3233/JPD-202019.
引用本文的文献
1
Barriers to clinical genetic testing in movement disorders.
Curr Opin Neurol. 2025 Aug 1;38(4):355-360. doi: 10.1097/WCO.0000000000001381. Epub 2025 May 21.
2
Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant.
NPJ Parkinsons Dis. 2025 Feb 23;11(1):34. doi: 10.1038/s41531-025-00884-6.
3
Global Perspectives on Returning Genetic Research Results in Parkinson Disease.
Neurol Genet. 2024 Dec 5;10(6):e200213. doi: 10.1212/NXG.0000000000200213. eCollection 2024 Dec.
4
Parkinson's Disease is Predominantly a Genetic Disease.
J Parkinsons Dis. 2024;14(3):467-482. doi: 10.3233/JPD-230376.
本文引用的文献
1
[Genetic revolution: New challenges and opportunities].
Rev Med Chil. 2022 Nov;150(11):1547-1548. doi: 10.4067/S0034-98872022001101547.
2
Genetic Movement Disorders Commonly Seen in Asians.
Mov Disord Clin Pract. 2023 May 8;10(6):878-895. doi: 10.1002/mdc3.13737. eCollection 2023 Jun.
3
The lived experience of stigma and parkinson's disease in Kenya: a public health challenge.
BMC Public Health. 2023 Feb 20;23(1):364. doi: 10.1186/s12889-023-15278-7.
4
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.
Mov Disord. 2023 Feb;38(2):286-303. doi: 10.1002/mds.29288. Epub 2023 Jan 24.
5
MDSGene: Extending the List of Isolated Dystonia Genes by VPS16, EIF2AK2, and AOPEP.
Mov Disord. 2023 Mar;38(3):507-508. doi: 10.1002/mds.29327. Epub 2023 Jan 20.
6
Health care implications of the Genetic Non-Discrimination Act: Protection for Canadians' genetic information.
Can Fam Physician. 2022 Sep;68(9):643-646. doi: 10.46747/cfp.6809643.
7
Underrepresented Populations in Parkinson's Genetics Research: Current Landscape and Future Directions.
Mov Disord. 2022 Aug;37(8):1593-1604. doi: 10.1002/mds.29126. Epub 2022 Jul 22.
8
Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority.
JAMA Neurol. 2022 Sep 1;79(9):929-936. doi: 10.1001/jamaneurol.2022.1783.
9
Is there a way to reduce the inequity in variant interpretation on the basis of ancestry?
Am J Hum Genet. 2022 Jun 2;109(6):981-988. doi: 10.1016/j.ajhg.2022.04.012.
10
Autosomal Recessive Cerebellar Ataxias in South America: A Multicenter Study of 1338 Patients.
Mov Disord. 2022 Aug;37(8):1773-1774. doi: 10.1002/mds.29046. Epub 2022 May 4.
Zotero 插件